American Kidney Fund Highlights Critical Public Health Education Programs at ASN Kidney Week, Booth #2717
November 07, 2019 09:00 ET
|
American Kidney Fund
WASHINGTON, D.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- At the American Society of Nephrology (ASN) Kidney Week 2019 Annual Meeting in Washington, D.C., the American Kidney Fund (AKF) is launching its...
Beyond Bananas™: American Kidney Fund Launches Campaign to Help Kidney Patients Reduce Risk and Effects of Hyperkalemia
August 26, 2019 10:08 ET
|
American Kidney Fund
Rockville, Md., Aug. 26, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched a new health education campaign, Beyond Bananas™, to increase kidney patients’ understanding of high...
American Kidney Fund and AstraZeneca Announce Campaign to Expand Education and Awareness of Hyperkalemia in Patients with Kidney Disease
May 29, 2019 10:41 ET
|
American Kidney Fund
Rockville, Md., May 29, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced AstraZeneca as the founding supporter to develop an education and awareness campaign that will aim...
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at AMCP Nexus 2018
October 22, 2018 08:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the Academy of Managed Care Pharmacy’s AMCP...
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2018
October 09, 2018 16:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the American Society of Nephrology (ASN) Kidney...
American Kidney Fund Launches Comprehensive New Kidney Disease Education Portal
May 16, 2018 11:30 ET
|
American Kidney Fund
ROCKVILLE, Md., May 16, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AFK) today unveiled CKD Central, a new free online education portal offering comprehensive information and resources on...
Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food
May 08, 2018 08:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced that the United States (U.S) Food and Drug Administration (FDA) approved a...
Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at the National Kidney Foundation 2018 Spring Clinical Meetings
April 11, 2018 08:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced results from a pooled analysis of three clinical trials evaluating the effects...
Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs
April 02, 2014 09:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of Vice...